Abstract
Background and Aims: A recently published RCT by our group demonstrated clinical benefits of a chronic disease management (CDM) model including non-significant trends of both improved hospital utilization (increased proportion of elective versus emergency admission) and reduced mortality (40% reduction). In this follow-up study, our aim was to assess the relative cost effectiveness of the CDM model when compared to usual care during the 12-month study period, using incremental costs per death avoided as the primary outcome.
Original language | English |
---|---|
Pages (from-to) | S121 |
Number of pages | 1 |
Journal | Journal of Hepatology |
Volume | 66 |
Issue number | S1 |
DOIs | |
Publication status | Published - 11 May 2017 |
Keywords
- Cost-effectiveness analysis
- Chronic disease management
- Chronic liver failure